PlainRecalls
FDA Drug Moderate Class II Ongoing

Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60

Reported: December 18, 2024 Initiated: December 12, 2024 #D-0130-2025

Product Description

Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60

Reason for Recall

CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit

Details

Recalling Firm
Ascend Laboratories, LLC
Units Affected
10,444 bottles
Distribution
Nationwide within the United States
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60. Recalled by Ascend Laboratories, LLC. Units affected: 10,444 bottles.
Why was this product recalled?
CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
Which agency issued this recall?
This recall was issued by the FDA Drug on December 18, 2024. Severity: Moderate. Recall number: D-0130-2025.